Susquehanna International Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.15M | Buy |
32,452
+21,637
| +200% | +$880K | ﹤0.01% | 7525 |
|
|
2025
Q4 | $439K | Buy |
10,815
+1,952
| +22% | +$84.9K | ﹤0.01% | 9106 |
|
|
2025
Q3 | $417K | Sell |
8,863
-44,291
| -83% | -$2.3M | ﹤0.01% | 9383 |
|
|
2025
Q2 | $2.77M | Buy |
53,154
+5,543
| +12% | +$304K | ﹤0.01% | 5121 |
|
|
2025
Q1 | $2.88M | Buy |
47,611
+17,878
| +60% | +$1.15M | ﹤0.01% | 4733 |
|
|
2024
Q4 | $2.03M | Buy |
29,733
+16,730
| +129% | +$1.17M | ﹤0.01% | 5278 |
|
|
2024
Q3 | $935K | Sell |
13,003
-11,541
| -47% | -$814K | ﹤0.01% | 6941 |
|
|
2024
Q2 | $1.7M | Sell |
24,544
-77
| -0.3% | -$5.62K | ﹤0.01% | 5409 |
|
|
2024
Q1 | $1.97M | Buy |
24,621
+5,075
| +26% | +$452K | ﹤0.01% | 5381 |
|
|
2023
Q4 | $2.14M | Buy |
19,546
+14,058
| +256% | +$1.45M | ﹤0.01% | 5202 |
|
|
2023
Q3 | $553K | Sell |
5,488
-4,465
| -45% | -$513K | ﹤0.01% | 7993 |
|
|
2023
Q2 | $1.35M | Sell |
9,953
-8,279
| -45% | -$1.01M | ﹤0.01% | 5993 |
|
|
2023
Q1 | $1.89M | Sell |
18,232
-11,438
| -39% | -$1.11M | ﹤0.01% | 5258 |
|
|
2022
Q4 | $2.63M | Buy |
29,670
+20,516
| +224% | +$1.7M | ﹤0.01% | 4227 |
|
|
2022
Q3 | $734K | Buy |
9,154
+6,074
| +197% | +$573K | ﹤0.01% | 7439 |
|
|
2022
Q2 | $295K | Sell |
3,080
-14,593
| -83% | -$1.75M | ﹤0.01% | 9600 |
|
|
2022
Q1 | $2.63M | Sell |
17,673
-2,998
| -15% | -$419K | ﹤0.01% | 4872 |
|
|
2021
Q4 | $2.93M | Buy |
20,671
+13,688
| +196% | +$1.94M | ﹤0.01% | 4687 |
|
|
2021
Q3 | $914K | Sell |
6,983
-6,339
| -48% | -$829K | ﹤0.01% | 7808 |
|
|
2021
Q2 | $1.83M | Buy |
13,322
+1,315
| +11% | +$180K | ﹤0.01% | 6117 |
|
|
2021
Q1 | $1.57M | Sell |
12,007
-1,675
| -12% | -$202K | ﹤0.01% | 6517 |
|
|
2020
Q4 | $1.53M | Sell |
13,682
-5,204
| -28% | -$493K | ﹤0.01% | 5698 |
|
|
2020
Q3 | $1.49M | Buy |
18,886
+10,763
| +133% | +$878K | ﹤0.01% | 5200 |
|
|
2020
Q2 | $585K | Sell |
8,123
-4,776
| -37% | -$332K | ﹤0.01% | 7034 |
|
|
2020
Q1 | $739K | Buy |
12,899
+3,864
| +43% | +$356K | ﹤0.01% | 6067 |
|
|
2019
Q4 | $1.01M | Sell |
9,035
-10,797
| -54% | -$1.15M | ﹤0.01% | 5502 |
|
|
2019
Q3 | $1.91M | Buy |
19,832
+9,389
| +90% | +$881K | ﹤0.01% | 4292 |
|
|
2019
Q2 | $894K | Buy |
10,443
+4,640
| +80% | +$381K | ﹤0.01% | 5922 |
|
|
2019
Q1 | $483K | Sell |
5,803
-6,708
| -54% | -$487K | ﹤0.01% | 6346 |
|
|
2018
Q4 | $803K | Buy |
+12,511
| New | +$856K | ﹤0.01% | 5103 |
|
|
2018
Q3 | – | Sell |
-12,632
| Closed | -$977K | – | 9300 |
|
|
2018
Q2 | $925K | Buy |
+12,632
| New | +$859K | ﹤0.01% | 5522 |
|
|
2017
Q3 | – | Sell |
-7,708
| Closed | -$387K | – | 8876 |
|
|
2017
Q2 | $393K | Buy |
+7,708
| New | +$381K | ﹤0.01% | 7083 |
|
|
2017
Q1 | – | Sell |
-38,842
| Closed | -$1.67M | – | 9028 |
|
|
2016
Q4 | $1.72M | Buy |
+38,842
| New | +$1.65M | ﹤0.01% | 4394 |
|
|
2016
Q1 | – | Sell |
-11,700
| Closed | -$515K | – | 9055 |
|
|
2015
Q4 | $515K | Sell |
11,700
-9,100
| -44% | -$395K | ﹤0.01% | 6711 |
|
|
2015
Q3 | $993K | Sell |
20,800
-3,733
| -15% | -$205K | ﹤0.01% | 5772 |
|
|
2015
Q2 | $1.43M | Buy |
24,533
+19,033
| +346% | +$1.03M | ﹤0.01% | 5418 |
|
|
2015
Q1 | $278K | Sell |
5,500
-790
| -13% | -$38.7K | ﹤0.01% | 8106 |
|
|
2014
Q4 | $283K | Sell |
6,290
-2,450
| -28% | -$103K | ﹤0.01% | 8222 |
|
|
2014
Q3 | $322K | Sell |
8,740
-9,859
| -53% | -$391K | ﹤0.01% | 7914 |
|
|
2014
Q2 | $821K | Buy |
+18,599
| New | +$843K | ﹤0.01% | 6466 |
|
|
2014
Q1 | – | Sell |
-6,929
| Closed | -$294K | – | 8928 |
|
|
2013
Q4 | $294K | Buy |
+6,929
| New | +$263K | ﹤0.01% | 7606 |
|
Other funds holding CNMD
VPM
VCM
CB
Susquehanna International Group's CNMD Position: Q1 2026 in Review
Susquehanna International Group increased its CONMED (CNMD) stake by 200% in Q1 2026, buying an estimated $880K and bringing the position to 32,452 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #7525.
Susquehanna International Group first reported a position in CNMD in Q4 2013 and has held it in 41 quarters since. The position peaked at $2.93M in Q4 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Susquehanna International Group held 32,452 shares of CONMED worth $1.15M as of Q1 2026.
- Susquehanna International Group bought 21,637 CONMED shares in Q1 2026, an estimated $880K.
- CONMED made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7525 holding.
- Susquehanna International Group first reported a position in CONMED in Q4 2013 and has held it in 41 quarters since.
- Susquehanna International Group's CONMED position peaked at $2.93M in Q4 2021.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.